CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Sales, net	$ 10,346,857	$ 10,335,031	$ 23,975,584	$ 29,307,413
Cost of sales:
Total cost of sales	10,361,667	6,014,350	22,509,389	21,740,297
Gross profit (loss)	(14,810)	4,320,681	1,466,195	7,567,116
Operating expenses:
Sales and marketing	1,749,123	1,368,112	4,658,465	4,263,735
Research and development	174,695	150,957	516,050	419,475
General and administrative	3,197,116	3,737,479	10,176,367	11,592,965
Total operating expenses	5,120,934	5,256,548	15,350,882	16,276,175
Loss from operations	(5,135,744)	(935,867)	(13,884,687)	(8,709,059)
Other income - TIA	1,469,688	1,447,975	4,429,383	4,479,773
Unrealized gain (loss) on debt and equity securities	1,449,825	(6,538,568)	1,402,660	(11,298,207)
Gain on sale of equity securities				5,574,791
Interest and other income	293,550	768,863	855,387	1,197,329
Interest expense	(30,489)	(36,087)	(95,789)	(117,110)
Loss before income taxes	(1,953,170)	(5,293,684)	(7,293,046)	(8,872,483)
Provision (benefit) for income taxes	(31,181)	(1,233,188)	8,364,200	(1,934,393)
Net loss	(1,921,989)	(4,060,496)	(15,657,246)	(6,938,090)
Preferred Stock dividend requirements	(57,611)	(58,111)	(172,832)	(174,335)
Net loss applicable to common shareholders	$ (1,979,600)	$ (4,118,607)	$ (15,830,078)	$ (7,112,425)
Basic loss per share	$ (0.07)	$ (0.14)	$ (0.53)	$ (0.24)
Diluted loss per share	$ (0.07)	$ (0.14)	$ (0.53)	$ (0.24)
Weighted average common shares outstanding:
Basic (in shares)	29,937,159	29,937,159	29,937,159	29,937,159
Diluted (in shares)	29,937,159	29,937,159	29,937,159	29,937,159
Cost of manufactured product
Cost of sales:
Total cost of sales	$ 9,477,097	$ 5,219,962	$ 20,379,228	$ 19,522,722
Royalty expense to shareholder
Cost of sales:
Total cost of sales	$ 884,570	$ 794,388	$ 2,130,161	$ 2,217,575